News
Norwegian software company Visma has provisionally chosen London over Amsterdam for its initial public offering next year, a ...
Hg Capital-backed Visma has provisionally chosen London for an initial public offering, according to a person familiar with ...
Private equity-backed software group Visma has chosen London over Amsterdam for the planned initial public offering of the ...
10h
Cycling Weekly on MSNVisma-Lease a Bike, Red Bull-Bora-Hansgrohe and UAE Team Emirates-XRG: The teams in special jerseys for the Tour de FranceAt least four teams will be in special kits for the 2025 Tour de France, with Red Bull-Bora-Hansgrohe revealing a new design ...
IDLProcycling on MSN9h
Just do it! Visma | Lease a Bike announces new partnership: "After all, they only go for the very best"The Tour de France is just around the corner, making this the most important time of the year for Visma | Lease a Bike. In ...
After 19 years in private hands, Visma is preparing for public scrutiny. UK-based buyout firm Hg first took the fast-growing ...
Reigning champion Tadej Pogacar begins his bid for a fourth Tour de France title on Saturday, seeking to cement his status ...
The 112th Tour de France gets underway in Lille on Saturday. Here's a complete guide to one of sport's most prestigious ...
Visma's IPO could mark a rare win for the UK’s troubled stock market — if Downing Street pulls through on its promised ...
4h
Cycling News on MSN'I think he'll be better than ever' – Jonas Vingegaard anticipates an even stronger version of Tadej Pogačar at the Tour de FranceJonas Vingegaard thinks his Tour de France rival Tadej Pogačar will be "better than ever" this July as the pair prepare to ...
8h
Cyclingnews on MSNThe three Tour de France stages Tadej Pogačar will want to win most – Sites of Jonas Vingegaard's previous successes bring 'revenge' into playIn the absence of any obvious weak points for Tadej Pogačar (UAE Team Emirates-XRG) at the 2025 Tour de France, one factor in favour of his biggest rival, Jonas Vingegaard (Visma-Lease a Bike), is the ...
The company's exit from the U.K. market would spark a major index re-weighting, given AstraZeneca is the most valuable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results